2023
DOI: 10.2174/1385272827666221027103050
|View full text |Cite
|
Sign up to set email alerts
|

Extravaganza of Nanobiotechnology in the Diagnosis and Treatment of Dementia Patients

Abstract: Dementia impairs memory, critical thinking, and decision-making. Alzheimer’s disease is caused by extracellular amyloid fibrils containing the peptide Amyloid beta (Aβ) accumulating in the brain. Alzheimer’s disease is the most common form of dementia. A slew of small molecule inhibitors developed over several decades has targeted dementia and related diseases. The drugs and inhibitors cannot cross the BBB due to their insurmountable nature. Many molecular nanomedicines have been developed that can cross the B… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 113 publications
0
1
0
Order By: Relevance
“…In conditions like Alzheimer’s disease and Parkinson’s disease, which affect the brain, the connection between the gut and the brain becomes very important. This connection, known as the gut–brain axis, involves messages that travel both ways between the gut and the brain [ 44 ]. An imbalance in the GM can contribute to inflammation and oxidative stress in the brain, which are linked to the development of these neurodegenerative diseases.…”
Section: Introductionmentioning
confidence: 99%
“…In conditions like Alzheimer’s disease and Parkinson’s disease, which affect the brain, the connection between the gut and the brain becomes very important. This connection, known as the gut–brain axis, involves messages that travel both ways between the gut and the brain [ 44 ]. An imbalance in the GM can contribute to inflammation and oxidative stress in the brain, which are linked to the development of these neurodegenerative diseases.…”
Section: Introductionmentioning
confidence: 99%